JP2017214410A5 - - Google Patents

Download PDF

Info

Publication number
JP2017214410A5
JP2017214410A5 JP2017135811A JP2017135811A JP2017214410A5 JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5 JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017135811 A JP2017135811 A JP 2017135811A JP 2017214410 A5 JP2017214410 A5 JP 2017214410A5
Authority
JP
Japan
Prior art keywords
thiophen
biphenyl
ethoxy
carbonyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017135811A
Other languages
English (en)
Japanese (ja)
Other versions
JP6414286B2 (ja
JP2017214410A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017214410A publication Critical patent/JP2017214410A/ja
Publication of JP2017214410A5 publication Critical patent/JP2017214410A5/ja
Application granted granted Critical
Publication of JP6414286B2 publication Critical patent/JP6414286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017135811A 2012-12-28 2017-07-11 ハロゲン置換へテロ環化合物 Active JP6414286B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012286425 2012-12-28
JP2012286425 2012-12-28
JP2013097171 2013-05-02
JP2013097171 2013-05-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014554626A Division JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018188246A Division JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Publications (3)

Publication Number Publication Date
JP2017214410A JP2017214410A (ja) 2017-12-07
JP2017214410A5 true JP2017214410A5 (OSRAM) 2018-02-08
JP6414286B2 JP6414286B2 (ja) 2018-10-31

Family

ID=51021433

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014554626A Active JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物
JP2017135811A Active JP6414286B2 (ja) 2012-12-28 2017-07-11 ハロゲン置換へテロ環化合物
JP2018188246A Active JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014554626A Active JP6176258B2 (ja) 2012-12-28 2013-12-27 ハロゲン置換へテロ環化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018188246A Active JP6569792B2 (ja) 2012-12-28 2018-10-03 ハロゲン置換へテロ環化合物

Country Status (13)

Country Link
US (2) US10000463B2 (OSRAM)
EP (2) EP2940013B1 (OSRAM)
JP (3) JP6176258B2 (OSRAM)
KR (1) KR102189166B1 (OSRAM)
CN (2) CN107698555B (OSRAM)
AU (1) AU2013366898B2 (OSRAM)
BR (1) BR112015015275B1 (OSRAM)
CA (1) CA2896701C (OSRAM)
DK (2) DK3360869T3 (OSRAM)
ES (2) ES2667798T3 (OSRAM)
MX (1) MX369801B (OSRAM)
RU (2) RU2649398C2 (OSRAM)
WO (1) WO2014104372A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3360869T3 (da) * 2012-12-28 2020-10-12 Ube Industries Halogen-substitueret heterocyklisk forbindelse anvendelig til behandlingen af sygdomme forårsaget af lpa.
DK2988743T3 (da) 2013-03-15 2021-03-01 Epigen Biosciences Inc Heterocykliske forbindelser, der kan anvendes til behandling af sygdom
JP2014231508A (ja) * 2013-05-02 2014-12-11 宇部興産株式会社 ハロゲン置換へテロ環化合物
AU2015281021B9 (en) * 2014-06-27 2019-03-28 Ube Corporation Salt of halogen-substituted heterocyclic compound
AU2016355863A1 (en) * 2015-11-20 2018-07-05 Ube Industries, Ltd. Pharmaceutical composition for treatment or prevention of nash
CN119823001A (zh) * 2019-07-30 2025-04-15 大正制药株式会社 拮抗lpa1受体的脲化合物
EP4058144A1 (en) 2019-11-15 2022-09-21 Gilead Sciences, Inc. Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
US11702407B2 (en) 2020-06-03 2023-07-18 Gilead Sciences, Inc. LPA receptor antagonists and uses thereof
TWI838626B (zh) 2020-06-03 2024-04-11 美商基利科學股份有限公司 Lpa受體拮抗劑及其用途
CN111909170B (zh) * 2020-09-11 2022-08-12 吉林奥来德光电材料股份有限公司 一种有机电致发光化合物、其制备方法以及包含该有机电致发光化合物的有机电致发光器件
CN117295717A (zh) 2021-05-11 2023-12-26 吉利德科学公司 Lpa受体拮抗剂及其用途
US11939318B2 (en) 2021-12-08 2024-03-26 Gilead Sciences, Inc. LPA receptor antagonists and uses thereof
CA3222642A1 (en) 2022-12-12 2024-06-12 Bmic Llc Downstream uses for briquettes and other forms of powder from asphalt shingle waste

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1258484B1 (en) * 2000-02-18 2009-01-14 Kyowa Hakko Kirin Co., Ltd. Novel isoxazole and thiazole compounds and use thereof as drugs
ATE447970T1 (de) 2001-02-08 2009-11-15 Ono Pharmaceutical Co Mittel zur behandlung von harnwegserkrankungen, umfassend mittel zur kontrolle des lpa-rezeptors
WO2005012269A1 (ja) * 2003-08-05 2005-02-10 Ajinomoto Co., Inc. 新規アゾール化合物
BRPI0920825A2 (pt) 2008-09-29 2015-12-22 Lilly Co Eli modulador seletivo do receptor de estrogênio
GB2466121B (en) * 2008-12-15 2010-12-08 Amira Pharmaceuticals Inc Antagonists of lysophosphatidic acid receptors
GB2470833B (en) 2009-06-03 2011-06-01 Amira Pharmaceuticals Inc Polycyclic antagonists of lysophosphatidic acid receptors
WO2011017350A2 (en) 2009-08-04 2011-02-10 Amira Pharmaceuticals, Inc. Compounds as lysophosphatidic acid receptor antagonists
GB2474120B (en) 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
GB2474748B (en) 2009-10-01 2011-10-12 Amira Pharmaceuticals Inc Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2011091167A2 (en) 2010-01-22 2011-07-28 The General Hospital Corporation Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases
WO2011159635A1 (en) 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions
US20130253019A1 (en) 2010-06-15 2013-09-26 John Howard Hutchinson Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
WO2011159633A1 (en) 2010-06-15 2011-12-22 Amira Pharmaceuticals, Inc. Inhalable formulations of lysophosphatdic acid receptor antagonists
AU2011338561A1 (en) 2010-12-07 2013-07-25 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis
HRP20180970T1 (hr) 2010-12-07 2018-08-10 Amira Pharmaceuticals, Inc. Policiklični lpa1 antagonist i njegove primjene
US8541587B2 (en) 2011-04-05 2013-09-24 Amira Pharmaceuticals, Inc. Lysophosphatidic acid receptor antagonists
WO2012138648A1 (en) * 2011-04-06 2012-10-11 Irm Llc Compositions and methods for modulating lpa receptors
AU2012296662A1 (en) 2011-08-15 2014-03-27 Intermune, Inc. Lysophosphatidic acid receptor antagonists
DK3360869T3 (da) * 2012-12-28 2020-10-12 Ube Industries Halogen-substitueret heterocyklisk forbindelse anvendelig til behandlingen af sygdomme forårsaget af lpa.

Similar Documents

Publication Publication Date Title
JP2017214410A5 (OSRAM)
JP2016153424A5 (OSRAM)
CL2014000270A1 (es) Compuestos derivados de 3,5-difenil diazoles sustituidos, inhibidores de la agregacion de proteinas. (divisional de la solicitud n° 1369-2010).
JP2013539454A5 (OSRAM)
JP2018024670A5 (OSRAM)
JP2009004351A5 (OSRAM)
EP2951579A4 (en) METHODS, SYSTEMS AND SOFTWARE FOR DETECTING BIOMOLECULES USING MODELS OF MULTIPLICATIVE FORM
JP2009530282A5 (OSRAM)
EA201170227A1 (ru) Имидазолкарбоксамиды
CL2021000373S1 (es) Contenedor. (divisional solicitud 202000878)
NO20082837L (no) Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner
JP2010070692A5 (OSRAM)
JP2010241791A5 (OSRAM)
DK3402784T3 (da) 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
JP2015199738A5 (OSRAM)
CY1115577T1 (el) Μεθοδος για την παρασκευη εναντιομερικως καθαρων αμινων
DK3402781T5 (da) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater
JP2011053031A5 (OSRAM)
JP2010243737A5 (OSRAM)
JP2017042232A5 (OSRAM)
JP2018128902A5 (OSRAM)
DE602006018910D1 (de) 1-(imidazolin-2-yl)amino-1,2-diphenylethan-verbindungen zur bekämpfung von tierpestkrankheiten
JP2011059293A5 (OSRAM)
JP2010217838A5 (OSRAM)
JP2018045476A5 (OSRAM)